Additional boosting to the RV144 vaccine regimen increased Fc-mediated effector function magnitude but not durability

The RV144 vaccine trial resulted in a decreased risk of HIV acquisition that was associated with a nonneutralizing antibody response. The objective of this study was to determine the impact of an additional boost to the RV144 vaccine regimen on antibody effector function and durability. DESIGN: RV30...

Descripción completa

Detalles Bibliográficos
Autores principales: Shubin, Zhanna, Stanfield-Oakley, Sherry, Puangkaew, Jiraporn, Pitisutthithum, Punnee, Nitayaphan, Sorachai, Gurunathan, Sanjay, Sinangil, Faruk, Chariyalertsak, Suwat, Phanuphak, Nittaya, Ake, Julie A., O’Connell, Robert J., Vasan, Sandhya, Akapirat, Siriwat, Eller, Michael A., Ferrari, Guido, Paquin-Proulx, Dominic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Basic Science: Concise Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355803/
https://www.ncbi.nlm.nih.gov/pubmed/37260254
http://dx.doi.org/10.1097/QAD.0000000000003611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355803/
https://www.ncbi.nlm.nih.gov/pubmed/37260254
http://dx.doi.org/10.1097/QAD.0000000000003611

Ejemplares similares